These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Mode of action of site-directed irreversible folate analogue inhibitors of thymidylate synthase. Lobo AP, Nair MG, Changchien L, Weichsel A, Montfort WR, Maley F. Biochemistry; 1998 Mar 31; 37(13):4535-42. PubMed ID: 9521774 [Abstract] [Full Text] [Related]
46. Inhibition of murine thymidylate synthase and human dihydrofolate reductase by 5,8-dideaza analogues of folic acid and aminopterin. Hynes JB, Patil SA, Tomazic A, Kumar A, Pathak A, Tan XH, Li XQ, Ratnam M, Delcamp TJ, Freisheim JH. J Med Chem; 1988 Feb 31; 31(2):449-54. PubMed ID: 3339615 [Abstract] [Full Text] [Related]
47. Quinazoline antifolates inhibiting thymidylate synthase: 2-desamino derivatives with enhanced solubility and potency. Jones TR, Thornton TJ, Flinn A, Jackman AL, Newell DR, Calvert AH. J Med Chem; 1989 Apr 31; 32(4):847-52. PubMed ID: 2704030 [Abstract] [Full Text] [Related]
48. Folate analogues. 32. Synthesis and biological evaluation of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid and related compounds. Patil SD, Jones C, Nair MG, Galivan J, Maley F, Kisliuk RL, Gaumont Y, Duch D, Ferone R. J Med Chem; 1989 Jun 31; 32(6):1284-9. PubMed ID: 2542557 [Abstract] [Full Text] [Related]
50. Synthesis and biological activity of 3- and 5-amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone. Liu MC, Lin TS, Cory JG, Cory AH, Sartorelli AC. J Med Chem; 1996 Jun 21; 39(13):2586-93. PubMed ID: 8691457 [Abstract] [Full Text] [Related]
51. Folate-based thymidylate synthase inhibitors as anticancer drugs. Jackman AL, Calvert AH. Ann Oncol; 1995 Nov 21; 6(9):871-81. PubMed ID: 8624289 [Abstract] [Full Text] [Related]
55. Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase. Duch DS, Banks S, Dev IK, Dickerson SH, Ferone R, Heath LS, Humphreys J, Knick V, Pendergast W, Singer S. Cancer Res; 1993 Feb 15; 53(4):810-8. PubMed ID: 8428362 [Abstract] [Full Text] [Related]
56. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. van Triest B, Pinedo HM, van Hensbergen Y, Smid K, Telleman F, Schoenmakers PS, van der Wilt CL, van Laar JA, Noordhuis P, Jansen G, Peters GJ. Clin Cancer Res; 1999 Mar 15; 5(3):643-54. PubMed ID: 10100718 [Abstract] [Full Text] [Related]
58. Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthase. Ward WH, Kimbell R, Jackman AL. Biochem Pharmacol; 1992 May 08; 43(9):2029-31. PubMed ID: 1596289 [Abstract] [Full Text] [Related]
59. Time dependence of DNA lesions and growth inhibition by ICI D1694, a new quinazoline antifolate thymidylate synthase inhibitor. Yin MB, Guimaraes MA, Zhang ZG, Arredondo MA, Rustum YM. Cancer Res; 1992 Nov 01; 52(21):5900-5. PubMed ID: 1394217 [Abstract] [Full Text] [Related]